Hot Papers

S. Coleman, "Why there is nothing rather than something: a theory of the cosmological constant," Nuclear Physics B, 310, 643-68, 12 December 1988. Sidney Coleman (Harvard University, Cambridge, Mass.): "The cosmological constant is a quantity that appears in Einstein's gravitational field equations. It can be thought of as the energy density of the ground state of quantum field theory, empty space. Experiment gives an upper bound on the constant (consistent with it vanishing altogether). Rough

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

S. Coleman, "Why there is nothing rather than something: a theory of the cosmological constant," Nuclear Physics B, 310, 643-68, 12 December 1988.

Sidney Coleman (Harvard University, Cambridge, Mass.): "The cosmological constant is a quantity that appears in Einstein's gravitational field equations. It can be thought of as the energy density of the ground state of quantum field theory, empty space. Experiment gives an upper bound on the constant (consistent with it vanishing altogether). Rough theoretical estimates predict a value several dozen orders of magnitude greater than the experimental upper bound. This is possibly the worst prediction in 20th-century physics and has been an embarrassment for many years.

"My paper extended earlier work by Hawking and Linde to offer a novel theory of the vanishing of the cosmological constant. The theory was (and is) highly speculative and I'm not sure why it has received so much more attention than its ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies